Health-related quality of life in adults with relapsed/refractory acute lymphoblastic leukemia treated with blinatumomab
Keyword(s):
Key Points Blinatumomab delays deterioration in HRQL in adults with R/R ALL.
2004 ◽
Vol 2004
(33)
◽
pp. 102-125
◽
2012 ◽
Vol 22
(3)
◽
pp. 677-681
◽
2018 ◽
Vol 27
(6)
◽
pp. 1431-1443
◽
2005 ◽
Vol 97
(23)
◽
pp. 1786-1786
◽
2019 ◽
Vol 36
(2)
◽
pp. 112-116